Thomson Reuters has created a $100m corporate venture capital fund to support and accelerate innovation for the "future of professionals". The post Thomson Reuters eyes ‘future of professionals’ with $100m venture capital fund first appeared
Lifeline Spac I, the special purpose acquisition company (Spac) set up by Finnish venture capital firm Lifeline Ventures, has listed on Nasdaq Helsinki.
PAI Partners is leaning towards a US initial public offering of Refresco, sources familiar with the matter said, setting up Europe's largest independent beverage bottler for a return to the public markets.
An autumn chill is gripping Europe’s crowded IPO market as investors give growing number of deals a frosty reception
OVHcloud is pricing its IPO at the bottom of the range
Emerging markets investor Actis has sealed a stunning fundraise for its latest energy-focused vehicle by hitting $6bn of investable capital. The post Actis soars to $6bn of capital for close of mammoth new emerging markets
Francisco Partners has followed yesterday's $2.2bn credit fund close with a growth investment in Paradigm, a provider of practice management software and integrated payments to the legal industry. The post Francisco Partners follows $2.2bn credit
Metals and mining-focused investor Tembo Capital Management has hit a $380m final close for its third flagship fund, well above its target. The post Tembo Capital soars past goal for latest metals, mining fundraise with
Global buyout giant Blackstone has brought in former JPMorgan exec Emily Yoder in the newly-created role of senior managing director for strategic relationship management. The post Blackstone brings in ex-JPMorgan exec Yoder in new senior
Early-stage investment house Spark Capital has confirmed it is eyeing almost $2bn across its latest hefty pair of fundraises. The post Spark Capital confirms almost $2bn goal for latest VC vehicle, growth capital fundraise first
Private equity titan Blackstone is reportedly eyeing up to $10bn for one of the largest growth capital funds ever raised. The post Blackstone ‘eyes up to $10bn’ for second growth vehicle, just months after record-breaking
The Riverside Company has agreed to sell policy management, training and wellness software provider Lexipol to fellow private equity house GTCR. The post Riverside sells 2014 investment Lexipol to fellow private equity house GTCR first appeared
Distressed investment specialist Cerberus Capital Management has bought cybersecurity, enterprise information technology, and telecommunications specialist NetCentrics. The post Federal cybersecurity, IT and telecoms provider NetCentrics gets Cerberus Capital backing first appeared on AltAssets Private Equity News.
Private equity major Permira has exited medical device maker Lyophilization Services of New England (LSNE) to PCI Pharma Services. The post Permira exits medical device maker LSNE after European market debut first appeared on AltAssets
Munich Re Ventures, the venture capital arm of German insurance major Munich Re Group, has hit a $500m final close for its second early-stage and growth investment fund. The post Munich RE venture arm doubles
Four Houston-based finance leaders have launched a new $275m private equity fund, GP Capital Partners, to extend their existing Genesis Park PE investing platform. The post Genesis Park PE team launch new $275m fund first
Miami private equity house Black Dragon Capital has struck a $386m final close for a new private equity fund targeting mid-market tech businesses disrupted by accelerated digitization. The post Black Dragon Capital brings in $386m
TA Associates has joined Partners Group to back European property manager Foncia by acquiring 25% stake in the company. Partners Group remains the controlling shareholder. The post TA Associates buys into Partners Group-backed European property
Buyout giant Blackstone has teamed with Hipgnosis Song Management for a $1bn investment plan aimed at acquiring music rights and manage catalogues. The post Second big music rights PE deal in a week sees Blackstone team
A string of private equity giants including Blackstone and Carlyle are reportedly circling GlaxoSmithKline’s consumer unit in a deal which could see it valued at up to £40bn. The post Buyout giants eye mammoth $54bn
